86 related articles for article (PubMed ID: 23385082)
1. Protein kinase C gamma (PKCγ) as a novel marker to assess the functional status of the corticospinal tract in experimental autoimmune encephalomyelitis (EAE).
Lieu A; Tenorio G; Kerr BJ
J Neuroimmunol; 2013 Mar; 256(1-2):43-8. PubMed ID: 23385082
[TBL] [Abstract][Full Text] [Related]
2. Changes in nociceptive sensitivity and object recognition in experimental autoimmune encephalomyelitis (EAE).
Olechowski CJ; Tenorio G; Sauve Y; Kerr BJ
Exp Neurol; 2013 Mar; 241():113-21. PubMed ID: 23291347
[TBL] [Abstract][Full Text] [Related]
3. Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE).
Olechowski CJ; Truong JJ; Kerr BJ
Pain; 2009 Jan; 141(1-2):156-64. PubMed ID: 19084337
[TBL] [Abstract][Full Text] [Related]
4. Long-term protection of central axons with phenytoin in monophasic and chronic-relapsing EAE.
Black JA; Liu S; Hains BC; Saab CY; Waxman SG
Brain; 2006 Dec; 129(Pt 12):3196-208. PubMed ID: 16931536
[TBL] [Abstract][Full Text] [Related]
5. The MAO inhibitor phenelzine improves functional outcomes in mice with experimental autoimmune encephalomyelitis (EAE).
Musgrave T; Benson C; Wong G; Browne I; Tenorio G; Rauw G; Baker GB; Kerr BJ
Brain Behav Immun; 2011 Nov; 25(8):1677-88. PubMed ID: 21723939
[TBL] [Abstract][Full Text] [Related]
6. Phenytoin protects spinal cord axons and preserves axonal conduction and neurological function in a model of neuroinflammation in vivo.
Lo AC; Saab CY; Black JA; Waxman SG
J Neurophysiol; 2003 Nov; 90(5):3566-71. PubMed ID: 12904334
[TBL] [Abstract][Full Text] [Related]
7. Characterization of relapsing-remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL/6 mice.
Berard JL; Wolak K; Fournier S; David S
Glia; 2010 Mar; 58(4):434-45. PubMed ID: 19780195
[TBL] [Abstract][Full Text] [Related]
8. Motor evoked potentials in a mouse model of chronic multiple sclerosis.
Amadio S; Pluchino S; Brini E; Morana P; Guerriero R; Martinelli Boneschi F; Comi G; Zaratin P; Muzio V; del Carro U
Muscle Nerve; 2006 Feb; 33(2):265-73. PubMed ID: 16307439
[TBL] [Abstract][Full Text] [Related]
9. Spinal cord maturation and locomotion in mice with an isolated cortex.
Han Q; Feng J; Qu Y; Ding Y; Wang M; So KF; Wu W; Zhou L
Neuroscience; 2013 Dec; 253():235-44. PubMed ID: 24012835
[TBL] [Abstract][Full Text] [Related]
10. Validation of a novel biomarker for acute axonal injury in experimental autoimmune encephalomyelitis.
Gresle MM; Shaw G; Jarrott B; Alexandrou EN; Friedhuber A; Kilpatrick TJ; Butzkueven H
J Neurosci Res; 2008 Dec; 86(16):3548-55. PubMed ID: 18709652
[TBL] [Abstract][Full Text] [Related]
11. Spinal cord histopathology of MOG peptide 35-55-induced experimental autoimmune encephalomyelitis is time- and score-dependent.
Recks MS; Addicks K; Kuerten S
Neurosci Lett; 2011 May; 494(3):227-31. PubMed ID: 21406210
[TBL] [Abstract][Full Text] [Related]
12. 2-BFI attenuates experimental autoimmune encephalomyelitis-induced spinal cord injury with enhanced B-CK, CaATPase, but reduced calpain activity.
Wang P; Wang ZW; Lin FH; Han Z; Hou ST; Zheng RY
Biochem Biophys Res Commun; 2011 Mar; 406(1):152-7. PubMed ID: 21303658
[TBL] [Abstract][Full Text] [Related]
13. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate.
Aharoni R; Vainshtein A; Stock A; Eilam R; From R; Shinder V; Arnon R
J Autoimmun; 2011 Nov; 37(3):228-41. PubMed ID: 21752599
[TBL] [Abstract][Full Text] [Related]
14. Opioid growth factor arrests the progression of clinical disease and spinal cord pathology in established experimental autoimmune encephalomyelitis.
Campbell AM; Zagon IS; McLaughlin PJ
Brain Res; 2012 Sep; 1472():138-48. PubMed ID: 22820301
[TBL] [Abstract][Full Text] [Related]
15. An electrophysiological model of spinal transmission deficits in mouse experimental autoimmune encephalomyelitis.
Hanak SE; Reilly EM; Wotanis J; Zhu B; Pulicicchio C; McMonagle-Strucko K; Wettstein JG; Black MD
J Pharmacol Exp Ther; 2004 Jan; 308(1):214-20. PubMed ID: 14566007
[TBL] [Abstract][Full Text] [Related]
16. Gene expression analysis suggests that 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by stimulating inflammatory cell apoptosis.
Spach KM; Pedersen LB; Nashold FE; Kayo T; Yandell BS; Prolla TA; Hayes CE
Physiol Genomics; 2004 Jul; 18(2):141-51. PubMed ID: 15138306
[TBL] [Abstract][Full Text] [Related]
17. Pain behaviors after spinal cord contusion injury in two commonly used mouse strains.
Kerr BJ; David S
Exp Neurol; 2007 Aug; 206(2):240-7. PubMed ID: 17586495
[TBL] [Abstract][Full Text] [Related]
18. The influence of uric acid treatments on liver glutathione system prevent oxidative damages in experimental autoimmune encephalomyelitis mice.
Allameh A; Maleklou N; Zargari M; Sanati MH
Neurosci Lett; 2008 Jul; 439(1):111-5. PubMed ID: 18501514
[TBL] [Abstract][Full Text] [Related]
19. Transient receptor potential vanilloid 1 channels modulate the synaptic effects of TNF-α and of IL-1β in experimental autoimmune encephalomyelitis.
Musumeci G; Grasselli G; Rossi S; De Chiara V; Musella A; Motta C; Studer V; Bernardi G; Haji N; Sepman H; Fresegna D; Maccarrone M; Mandolesi G; Centonze D
Neurobiol Dis; 2011 Sep; 43(3):669-77. PubMed ID: 21672630
[TBL] [Abstract][Full Text] [Related]
20. Increased X-linked inhibitor of apoptosis protein (XIAP) expression exacerbates experimental autoimmune encephalomyelitis (EAE).
Moore CS; Hebb AL; Blanchard MM; Crocker CE; Liston P; Korneluk RG; Robertson GS
J Neuroimmunol; 2008 Oct; 203(1):79-93. PubMed ID: 18687476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
